Our researchers who undertake the research projects at INFANT
Our multi-disciplinary team of investigators implements the INFANT research programme of cutting-edge innovations and world-first technologies.
Clinical research fellow
Farah is interested in early brain development and factors affecting neurodevelopmental outcome in neonates. She is currently involved in the ANSeR study- Algorithm for Neonatal Seizure Recognition.
Prof. Stefan Andersson-Engels is since 2016 Head of Biophotonics at Tyndall National Institute, University College Cork.
Co-investigator on PiNPoiNT
Ann-Marie is currently a co-investigator on PiNPoiNT, Personalised Nutrition for the Preterm Infant, which is a Science Foundation Ireland-funded study that will devise and implement digital systems for real-time monitoring of nutritional support in preterm infants.
Gerard Clarke is a lecturer in the Department of Psychiatry and Neurobehavioural Science. His research interests include translational biomarkers of stress-related neuropsychiatric disorders, the impact of the gut microbiome on brain and behaviour across the life span and microbial regulation of tryptophan metabolism.
Software Research Engineer
Denis has designed, developed, tested and validated all of the software that makes up the ANSeR system. Denis has written all of the software documents required for the ANSeR Quality Management System (QMS) which has resulted in the product being validated by the relevant competent authorities in Ireland, the UK and Europe. Denis has helped integra...
HRB Principal Investigator
Jane's interests are in the areas of application of proteomics, mass spectrometry, bioinformatics, integrated-omics analyses, and systems biology to study molecular pathways implicated in human health and disease, with a particular focus on neurodevelopmental and neuropsychiatric disorders.
Peter is a Consultant Neonatologist in CUMH
Aisling is currently undertaking a PhD in the area of Neonatal Encephalopathy. Aisling is interested in the early neurophysiological changes that occur following birth in infants with HIE and determining whether the evolution of these changes can predict eligibility for therapy and long term outcome.